WallStreetZenWallStreetZen

NASDAQ: PETS
Petmed Express Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

PETS past revenue growth

How has PETS's revenue growth performed historically?
Company
6.92%
Industry
8.58%
Market
16.96%
PETS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PETS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PETS's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PETS earnings and revenue history

Current Revenue
$277.0M
Current Earnings
-$2.7M
Current Profit Margin
-1%

PETS Return on Equity

Current Company
-2.5%
Current Industry
2.6%
Current Market
188%
PETS's Return on Equity (-2.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PETS announces earnings.

PETS Return on Assets

Current Company
-1.6%
Current Industry
0.4%
PETS is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PETS Return on Capital Employed

Current Company
-3.11%
Current Industry
-0.1%
PETS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PETS vs Pharmaceutical Retailer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PETS$276.97M$3.02M-$2.66M-0.65%N/A
YI$2.08BN/A-$54.54M+52.16%N/A
HITI$497.66M$3.64M-$35.54M+153.45%N/A
BIMI$5.85M-$14.65M-$14.76M-2.00%N/A
MEDS$8.27M-$15.60M-$17.84M+16.64%N/A
View Top Pharmaceutical Retailer Stocks

PETS earnings dates

Next earnings date
May 20, 2024

Petmed Express Earnings & Revenue FAQ

What were PETS's earnings last quarter?

On Invalid Date, Petmed Express (NASDAQ: PETS) reported Q4 2023 earnings per share (EPS) of -$0.10, up 900% year over year. Total Petmed Express earnings for the quarter were -$2.03 million. In the same quarter last year, Petmed Express's earnings per share (EPS) was -$0.01.

If you're new to stock investing, here's how to buy Petmed Express stock.

What was PETS's earnings growth in the past year?

As of Q2 2024, Petmed Express's earnings has grown year over year. Petmed Express's earnings in the past year totalled -$2.66 million.

What is PETS's earnings date?

Petmed Express's earnings date is Invalid Date. Add PETS to your watchlist to be reminded of PETS's next earnings announcement.

What was PETS's revenue last quarter?

On Invalid Date, Petmed Express (NASDAQ: PETS) reported Q4 2023 revenue of $65.32 million up 10.95% year over year. In the same quarter last year, Petmed Express's revenue was $58.87 million.

What was PETS's revenue growth in the past year?

As of Q2 2024, Petmed Express's revenue has grown 6.92% year over year. This is 1.66 percentage points lower than the US Pharmaceutical Retailers industry revenue growth rate of 8.58%. Petmed Express's revenue in the past year totalled $276.97 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.